Moderna's Stephane Bancel Dumping Stocks Regularly
Moderna’s CEO Stephane Bancel has been regularly dropping thousands of shares of his company’s stock prior to the much anticipated trial data for Moderna’s COVID-19 vaccine trial candidate, mRNA-1273. How confident can he be in the long-term situation for his company? Does he think his company is overvalued? He’s filed numerous Form-4 document with the Securities and Exchange Commission. There are so many that it’s impossible to ignore them.